Article citationsMore >>

Est¨¨ve, C., Samson, M., Guilhem, A., Nicolas, B., Leguy-Seguin, V., Berthier, S., Bonnotte, B.andAudia, S, ¡°Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients,¡± Plos One, 12(10). e0187296. Oct. 2017.

has been cited by the following article:

Article

Thrombocytopenia in a Patient with Graves¡¯ Disease: An Uncommon Association of Two Common Autoimmune Diseases

1Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh


American Journal of Medical Case Reports. 2020, Vol. 8 No. 1, 14-17
DOI: 10.12691/ajmcr-8-1-4
Copyright © 2019 Science and Education Publishing

Cite this paper:
Shahed- Morshed, Hasanat MA, Fariduddin Md, Nusrat- Sultana, Mahmood T, Ghani MH, Faisal I, Sharmin- Jahan. Thrombocytopenia in a Patient with Graves¡¯ Disease: An Uncommon Association of Two Common Autoimmune Diseases. American Journal of Medical Case Reports. 2020; 8(1):14-17. doi: 10.12691/ajmcr-8-1-4.

Correspondence to: Shahed-  Morshed, Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh. Email: shahedk62@gmail.com

Abstract

We describe a 65-year-old male of Graves¡¯ disease with thyroid-associated orbitopathy who developed thrombocytopenia during the course of illness. Clinical features, temporal relationship with drugs and investigations supported the diagnosis of immune thrombocytoenic purpura. Several immunosuppressive drugs failed to improve thrombocytopenia. At last platelet count returned back to normal and remained stable with addition of dapsone and restoration of euthyroidism.

Keywords